UniProt ID | CSPG4_MOUSE | |
---|---|---|
UniProt AC | Q8VHY0 | |
Protein Name | Chondroitin sulfate proteoglycan 4 | |
Gene Name | Cspg4 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 2327 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein Extracellular side . Apical cell membrane Single-pass type I membrane protein Extracellular side . Cell projection, lamellipodium membrane Single-pass type I membrane protein Extracellular side |
|
Protein Description | Proteoglycan playing a role in cell proliferation and migration which stimulates endothelial cells motility during microvascular morphogenesis. May also inhibit neurite outgrowth and growth cone collapse during axon regeneration. Cell surface receptor for collagen alpha 2(VI) which may confer cells ability to migrate on that substrate. Binds through its extracellular N-terminus growth factors, extracellular matrix proteases modulating their activity. May regulate MPP16-dependent degradation and invasion of type I collagen participating in melanoma cells invasion properties. May modulate the plasminogen system by enhancing plasminogen activation and inhibiting angiostatin. Functions also as a signal transducing protein by binding through its cytoplasmic C-terminus scaffolding and signaling proteins. May promote retraction fiber formation and cell polarization through Rho GTPase activation. May stimulate alpha-4, beta-1 integrin-mediated adhesion and spreading by recruiting and activating a signaling cascade through CDC42, ACK1 and BCAR1. May activate FAK and ERK1/ERK2 signaling cascades.. | |
Protein Sequence | MLLGPGHPLSAPALALALTLALLVRSTAPASFFGENHLEVPVPSALTRVDLLLQFSTSQPEALLLLAAGQDDHLLLQLHSGCLQVRLALGQKELKLQTPADTVLSDSAPHTVVLTVSDSWAVLSVDGVLNTSAPIPRASHLKATYGLFVGSSGSLDLPYLKGISRPLRGCLHSAILNGRNLLRPLTSDVHEGCAEEFSAGDEVGLGFSGPHSLAAFPAWSTREEGTLEFTLTTRSQQAPLAFQAGDKRGNFIYVDIFEGHLRAVVEKGQGTMLLRNSVPVADGQPHEVSVHIDVHRLEISVDQYPTRTFNRGVLSYLEPRGSLLLGGLDTEASRHLQEHRLGLAPGAANISLVGCIEDFSVNGRRQGLRDAWLTRDMSAGCRPEEDEYEEEVYGPYETFSTLAPEAWPAMELPEPCIPEPGLPAVFANFTQLLTISPLVVAEGGTAWLEWRHVQPTLDLTEAELRKSQVLFSVSQSARHGDLELDILGAQTRKMFTLLDVVNRKARFVHDGSEDTSDQLMLEVSVTARAPVPSCLRRGQIYILPIQVNPVNDPPRIIFPHGSLMVILEHTQKPLGPEIFQAYDPDSACEGLTFQLLGVSSGVPVEHRDQPGEPATEFSCRELEVGDIVYVHRGGPAQDLTFRVSDGMQASAPATLKVVAVRPAIQILHNTGLHLAQGSAAAILPANLSVETNAVGQDVSVLFRVTGTLQFGELQKQGAGGVEGTEWWDTLAFHQRDVEQGRVRYLSTDPQHHTQDTVEDLILEVQVGQETLSNLSFPVTIQRATVWMLRLEPLHTQNPHQETLTPAHLEASLEEEEEEGSPQPHTFHYELVQAPRRGNLLLQGTRLSDGESFSQSDLQAGRVTYRATMRTSEAADDSFRFRVTSPPHFSPLYTFPIHIGGDPNAPVLTNVLLMVPEGGEGVLSADHLFVKSLNSASYLYEVMEQPHHGKLAWRDPKGKSTPVTSFTNEDLLHGRLVYQHDDSETIEDDIPFVATRQGEGSGDMAWEEVRGVFRVAIQPVNDHAPVQTISRVFHVARGGQRLLTTDDVAFSDADSGFSDAQLVLTRKDLLFGSIVAMEEPTRPIYRFTQEDLRKKQVLFVHSGADHGWLQLQVSDGQHQATAMLEVQASEPYLHVANSSSLVVPQGGQGTIDTAVLQLDTNLDIRSGNEVHYHVTAGPQWGQLLRDGQSVTSFSQRDLLDGAILYSHNGSLSPQDTLAFSVAAGPVHTNTFLQVTIALEGPLAPLQLVQHKKIYVFQGEAAEIRRDQLEVVQEAVLPADIMFSLRSPPNAGYLVMVSHGASAEEPPSLDPVQSFSQEAVNSGRVLYLHSRPGAWSDSFSLDVASGLGDPLEGISVELEVLPTVIPLDVQNFSVPEGGTRTLAPPLVQITGPYFPTLPGLVLQVLEPPQHGALQKEDHSQDGSLSTFSWREVEEQLIRYVHDGSETQTDAFVLLANASEMDRQSQPVAFTITILPVNDQPPVLTTNTGLQIWEGAIVPIPPEALRGTDNDSGPEDLVYTIEQPSNGRIALRVAPDTEVHRFTQAQLDSGLVLFSHRGALEGGFHFDLSDGAHTSPGHFFRVVAQKQALLSLEGTRKLTVCPESVQPLSSQSLSASSSTGADPRHLLYRVVRGPQLGRLLHAQQGSAEEVLVNFTQAEVNAGNILYEHEMSSEPFWEAHDTIGLLLSSPPARDLAATLAVMVSFDAACPQRPSRLWKNKGLWVPEGQRAKITVAALDAANLLASVPASQRSRHDVLFQVTQFPTRGQLLVSEEPLHARRPYFLQSELAAGQLVYAHGGGGTQQDGFRFRAHLQGPTGTSVAGPQTSEAFVITVRDVNERPPQPQASIPLRVTRGSRAPVSRAQLSVVDPDSAPGEIEYEVQRAPHNGFLSLAGDNTGPVTHFTQADVDAGRLAFVANGSSVAGVFQLSMSDGASPPIPMSLAVDVLPSTIEVQLRAPLEVPQALGRTSLSRQQLQVISDREEPDVAYRLTQGPLYGQLLVGGQPASAFSQLQVDQGDVVFVFTNFSSSQDHFKVVALARGVNASATVNVTVQALLHVWAGGPWPQGTTLRLDPTVLDASELANRTGSMPHFRLLAGPRYGRVVRVSQGRTESRSNQLVEHFTQRDLEEGQLGLEVGKPEGRSTGPAGDRLTLELWAKGVPPAVALLDFATEPYHAAKSYSVALLSVPEAVRTETEKPGRSVPTGQPGQAASSPVPTAAKGGFLGFLEANMFSIIIPVCLILLLLALILPLLFYLRKRNKTGKHDVQVLTAKPRNGLAGDTETFRKVEPGQAIPLITVPGQGPPPGGQPDPELLQFCRTPNPALRNGQYWV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
130 | N-linked_Glycosylation | LSVDGVLNTSAPIPR EEECCEECCCCCCCC | 29.58 | 19656770 | |
349 | N-linked_Glycosylation | GLAPGAANISLVGCI CCCCCCCEEEEEEEE | 24.69 | - | |
428 | N-linked_Glycosylation | GLPAVFANFTQLLTI CCCCHHCCCCCCEEC | 29.09 | - | |
686 | N-linked_Glycosylation | AAAILPANLSVETNA EEEEEECCEEEECCC | 30.80 | - | |
773 | N-linked_Glycosylation | VGQETLSNLSFPVTI CCCHHHHCCCCCEEE | 42.70 | - | |
1000 | O-linked_Glycosylation | ATRQGEGSGDMAWEE EEECCCCCCCCHHHH | 27.58 | - | |
1136 | N-linked_Glycosylation | EPYLHVANSSSLVVP CCEEEECCCCCEEEC | 41.14 | - | |
1207 | N-linked_Glycosylation | GAILYSHNGSLSPQD CCEEEEECCCCCHHH | 35.49 | - | |
1285 | Phosphorylation | DIMFSLRSPPNAGYL HEEEEECCCCCCCEE | 50.42 | 23649490 | |
1291 | Phosphorylation | RSPPNAGYLVMVSHG CCCCCCCEEEEEECC | 8.16 | 26160508 | |
1296 | Phosphorylation | AGYLVMVSHGASAEE CCEEEEEECCCCCCC | 9.71 | 28638064 | |
1300 | Phosphorylation | VMVSHGASAEEPPSL EEEECCCCCCCCCCC | 40.58 | 24453211 | |
1306 | Phosphorylation | ASAEEPPSLDPVQSF CCCCCCCCCCCCCCC | 57.00 | 23649490 | |
1312 | Phosphorylation | PSLDPVQSFSQEAVN CCCCCCCCCCHHHHH | 27.40 | 23649490 | |
1369 | N-linked_Glycosylation | VIPLDVQNFSVPEGG EEECCCCCCCCCCCC | 30.89 | 19656770 | |
1454 | N-linked_Glycosylation | DAFVLLANASEMDRQ HEEEEEECHHHCCCC | 43.92 | 19656770 | |
1505 | Phosphorylation | PPEALRGTDNDSGPE CHHHHCCCCCCCCCC | 25.79 | 26525534 | |
1509 | Phosphorylation | LRGTDNDSGPEDLVY HCCCCCCCCCCCEEE | 63.60 | 26525534 | |
1592 | Phosphorylation | ALLSLEGTRKLTVCP HHHHCCCCCCEEECC | 18.43 | 28059163 | |
1650 | N-linked_Glycosylation | SAEEVLVNFTQAEVN CHHHHEEEEEHHEEH | 30.04 | - | |
1829 | Phosphorylation | TSEAFVITVRDVNER CCCEEEEEEEECCCC | 12.27 | - | |
1914 | N-linked_Glycosylation | GRLAFVANGSSVAGV CCEEEEECCCCEEEE | 45.65 | - | |
2021 | N-linked_Glycosylation | DVVFVFTNFSSSQDH CEEEEEECCCCCCCC | 24.28 | 19656770 | |
2039 | N-linked_Glycosylation | VALARGVNASATVNV EEEECCCCCCCEECH | 30.88 | - | |
2045 | N-linked_Glycosylation | VNASATVNVTVQALL CCCCCEECHHHHHHH | 21.27 | - | |
2080 | N-linked_Glycosylation | LDASELANRTGSMPH ECHHHHHHHHCCCCC | 55.46 | 19656770 | |
2257 | Phosphorylation | YLRKRNKTGKHDVQV HHHHHCCCCCCCEEE | 55.82 | - | |
2315 | Phosphorylation | ELLQFCRTPNPALRN HHHHHHCCCCHHHCC | 28.71 | 26824392 | |
2325 | Phosphorylation | PALRNGQYWV----- HHHCCCCCCC----- | 14.99 | 29514104 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
2257 | T | Phosphorylation | Kinase | PRKCA | P20444 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CSPG4_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CSPG4_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of CSPG4_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"The mouse C2C12 myoblast cell surface N-linked glycoproteome:identification, glycosite occupancy, and membrane orientation."; Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I.,Bausch-Fluck D., Elliott S.T., Boheler K.R., Van Eyk J.E.,Wollscheid B.; Mol. Cell. Proteomics 8:2555-2569(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-130; ASN-1369; ASN-1454;ASN-2021 AND ASN-2080, AND MASS SPECTROMETRY. |